Please login to the form below
Abasaglar
This page shows the latest Abasaglar news and features for those working in and with pharma, biotech and healthcare.
Lilly and Boehringer launch first Lantus clone Basaglar in US
Lilly and Boehringer's product is already on the market in Europe as Abasaglar.
Latest news
-
CHMP recommends Merck & Co's Lantus biosimilar
Last year, Sanofi settled another Lantus patent infringement lawsuit with Lilly, after its Lantus 'follow-on' product Abasaglar won FDA approval in December. ... As part of that deal Lilly agreed to pay royalties to the French pharma group in exchange
-
Sanofi fires off another lawsuit against a Lantus biosimilar
Lilly also agreed to hold off on launching its pen injector formulation of the Basaglar product - already on the market as Abasaglar in Europe - until 15 December 2016.
-
Lilly's Lantus 'follow-on' approved in the US
The Lantus 'follow-on' was awarded tentative approval by the FDA in August 2014 and has also been approved in Europe as Abasaglar and has been launched in 11 countries to
-
Lilly set to launch Lantus biosimilar in the US next year
Lilly and Boehringer have already started to roll out their biosimilar in Europe under the Abasaglar brand name, including in the UK, but delaying direct competition in the US will avoid
-
New data arms Novo Nordisk for insulin battle with Sanofi
With Eli Lilly and Boehringer Ingelheim's biosimilar Lantus product Abasaglar now available in its first European countries, the basal insulin market looks set to become a two-tier segment, split
More from news
Approximately 1 fully matching, plus 7 partially matching documents found.
Latest Intelligence
-
Could formulary intelligence be your brand differentiator?
Abasaglar – a biosimilar to Lantus (diabetes), offering a money-saving value proposition for medicines management.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Manager
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- MHRA to introduce new UK clinical trials framework
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- 2023 PM Society Awards – winners announced
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Humancomms for humancare?
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Trust me, I’m from pharma
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- Genmab hires first chief operating officer
- A relentless commitment to neuroscience
PMHub
Redbow Consulting Group
Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...
Latest intelligence
- Humancomms for humancare?
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
